Related Experiment Video

Updated: Jan 28, 2026

Effects of Exposure of Formaldehyde to a Rat Model of Atopic Dermatitis Induced by Neonatal Capsaicin Treatment
06:47

Effects of Exposure of Formaldehyde to a Rat Model of Atopic Dermatitis Induced by Neonatal Capsaicin Treatment

Published on: September 27, 2017

10.1K

Topical Treatment for the Management of Atopic Dermatitis

Peter W. Hashim, Tinley Chen, Adelaide A. Hebert

    Journal of Drugs in Dermatology : JDD
    |February 28, 2019
    PubMed

    Insights

    Topical corticosteroids are essential for managing atopic dermatitis in children, a condition with increasing prevalence. These treatments help reduce symptoms and flare frequency, despite potential bacterial infections.

    Area of Science:

    • Dermatology
    • Pediatrics

    Background:

    • Atopic dermatitis affects up to 20% of children globally.
    • The prevalence of atopic dermatitis is increasing.
    • Secondary bacterial infections can complicate atopic dermatitis management.

    Purpose of the Study:

    • To review the role of topical corticosteroids in atopic dermatitis treatment.
    • To discuss current treatment options for pediatric atopic dermatitis.

    Main Methods:

    • Literature review of treatment options for atopic dermatitis.
    • Analysis of the role of topical corticosteroids in current treatment guidelines.

    Main Results:

    • Topical corticosteroids remain a cornerstone of atopic dermatitis management.
    • Several non-systemic treatment options have emerged recently.

    Conclusions:

    • Topical corticosteroids are fundamental in managing pediatric atopic dermatitis.
    • Effective disease control involves symptom reduction and flare prevention.

    More Related Videos

    Optimized Management of Endovascular Treatment for Acute Ischemic Stroke09:21

    Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

    Published on: January 18, 2018

    12.5K
    Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis10:27

    Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis

    Published on: December 15, 2011

    25.0K

    Related Concept Videos

    Tonsillitis II: Management01:26

    Tonsillitis II: Management

    This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
    425
    Impression Management Techniques I: Managing Appearances01:29

    Impression Management Techniques I: Managing Appearances

    Appearance is a multidimensional aspect of self-presentation that encompasses observable attributes such as clothing, grooming, speech, and nonverbal behavior. These elements are often strategically managed to align with socially constructed expectations in different settings. For instance, individuals tailor their appearance during job interviews, social gatherings, or athletic events to meet the perceived norms of those environments.Contextual Adaptation and Social SignalsThe research...
    214
    Managing Impressions01:19

    Managing Impressions

    Impression management encompasses individuals' deliberate efforts to shape how others perceive them during social interactions. This behavior is often employed to conform to social norms, secure approval, or pursue specific goals. While it involves selective self-presentation, it is not necessarily deceptive; individuals frequently present authentic aspects of themselves that align with situational demands.Common strategies include:Ingratiation: where individuals use flattery or agreeableness...
    169
    Management of Insomnia01:19

    Management of Insomnia

    The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
    612
    Cystic Fibrosis: Management01:24

    Cystic Fibrosis: Management

    Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
    Sinus disease and chronic...
    520
    Angina IV: Management01:26

    Angina IV: Management

    IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
    277